13F filing recap · Q2 2014
What did Egerton Capital buy in Q2 2014?
Reported stock-position changes between this filing and the previous one.
Stock value
$6.31B
Positions
33
Estimated turnover
81.2%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
GILDGilead Sciences, Inc.$509.79Mreported value+6.15M sharesCCICrown Castle Inc.$213.05Mreported value+2.87M sharesLYBLyondellbasell Industries N.v.$140.31Mreported value+1.44M sharesBIDUBaidu, Inc.$127.66Mreported value+683.4K sharesMCKMckesson Corporation$99.87Mreported value+536.3K sharesMAMastercard Inc$74.20Mreported value+1.01M sharesSLBSlb Limited/nv$70.09Mreported value+594.2K sharesHALHalliburton Company$69.70Mreported value+981.6K sharesHLTHilton Worldwide Holdings Inc.$61.48Mreported value+2.64M sharesOIO-I Glass, Inc.$6.02Mreported value+173.7K shares